Form D · Other Health Care

TriAgenics, Inc

Redmond, OR · CIK 0001732710

Offering snapshot reported Apr 17, 2025 · SEC filing

Reported sold
$500K
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 11, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2025Initial$500,000No comparison1SEC filing
Sep 2, 2021Amendment$1,912,302No comparisonNot reportedSEC filing
Aug 5, 2020InitialYet to sellNo comparison0SEC filing
Mar 8, 2018Initial$1,400,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-543963

Source: Form D, filed Apr 17, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Joseph Chopack Director
John Chopack, Jr. Director
Leigh Colby Director, Executive
Mike Diers Promoter
Walter Diers Director, Executive
Jeffrey Miles Jacobs Director
George Shahin Director
David Scott Thrower Director, Executive
David Paul Waston Director
David Watson Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
525 Sw Umatilla Avenue Suite 102
Redmond, OR, 97756